Understanding Biosimilars

New biosimilars have been FDA-approved, and more are coming.


Drugs in the category called biologics are used to treat a variety of diseases, including inflammatory forms of arthritis, such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. They may be prescribed for these conditions when a person no longer gets adequate symptom relief from another disease-modifying antirheumatic drug (DMARD), such as methotrexate.

To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access